搜尋結果
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 6 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 6 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Wall St Week Ahead Rally in U.S. big tech stocks may be getting stretched
Reuters· 6 小時前A blistering rally in U.S. big tech stocks may be due for a breather, offering hope for market ...
US regulators single out four banks for flawed 'living wills'
Reuters· 7 小時前U.S. bank regulators said four major banks had shortcomings in their "living wills" - ...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters· 7 小時前The approval under the agency's accelerated process was based on an early- to mid-stage ...
US Supreme Court says citizens can't sue over foreign spouses' visa denials
Reuters· 8 小時前The U.S. Supreme Court on Friday said the constitutional rights of U.S. citizens are not ...
US lawsuit against TikTok to focus on childrens' privacy
Reuters· 9 小時前The U.S. Department of Justice plans to focus an upcoming lawsuit against TikTok on allegations ...
'Rust' armorer denied immunity to testify at Alec Baldwin trial
Reuters· 9 小時前A New Mexico judge on Friday denied the prosecution's request that convicted ...
U.S. bank regulators find flaws in four big bank 'living wills'
Reuters· 10 小時前U.S bank regulators dinged Bank of America, Citigroup, Goldman Sachs and JPMorgan Chase Friday ...
UK's Labour considers upping capital gains and inheritance taxes, Guardian reports
Reuters· 10 小時前Britain's opposition Labour Party is considering raising capital gains tax and altering ...